Sort
48,018 grants matching “immunotherapy”
Effects of autoantibodies on synaptic transmission in the retina
$462,428Catherine W Morgans · Oregon Health & Science University · R01 · FY2014 · EY
Fatty acid signaling in the pancreatic tumor microenvironment
$462,414Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$462,269Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$462,250Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$462,250Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$462,141Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2025 · CA
Pathogenesis and treatment of sporadic Inclusion Body Myositis in mouse models.
$462,140Thomas E. Lloyd · Johns Hopkins University · R01 · FY2023 · AR
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$462,127Andrew E Aplin · Thomas Jefferson University · R01 · FY2024 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$462,107Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2014 · CA
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer
$462,092Sally E Dickinson · University Of Arizona · UG3 · FY2025 · CA
APOBEC3 Proteins in HIV Restriction
$462,062Reuben S Harris · University Of Minnesota · R37 · FY2016 · AI
Project 2: The Impact of Immunotherapy on Human Vaccination
$462,053E. John Wherry · Massachusetts General Hospital · U19 · FY2023 · AI
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$462,010Rong Li · George Washington University · R01 · FY2021 · CA
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
$461,996Abraham Ari Hakimi · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Project 3: Adaptive immunity to MCPyV in Merkel cell carcinoma
$461,978David M Koelle · University Of Washington · P01 · FY2019 · CA
Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approaches
$461,922Billur Akkaya · Ohio State University · DP2 · FY2024 · AI
Novel Nanoparticle Respiratory Tract Mucosal Vaccine
$461,920Frederick D Quinn · University Of Georgia · R61 · FY2024 · AI
DNA damage response and cancer immunity
$461,897Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
DNA damage response and cancer immunity
$461,897Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$461,852Todd W Ridky · University Of Pennsylvania · R01 · FY2019 · CA
Developmental Funds
$461,844Peter A Jones · University Of Southern California · P30 · FY2013 · CA
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
$461,830Young J. Kim · Vanderbilt University Medical Center · R01 · FY2020 · DE
Computer aided diagnosis of cancer metastases in the brain
$461,828Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2016 · LM
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
$461,824Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.
$461,820Zelig Eshhar · Tel-Aviv Sourasky Medical Center · R01 · FY2015 · EB